Young Wexford respiratory consultant dies suddenly
The son of a former Trinidad and Tobago Chief Justice was only 39 years old
Tributes have been paid to a young respiratory consultant who died suddenly.
Dr Keshav Sharma was 39 years of age when he passed away last week (January 11), three days after his birthday.
He was a consultant respiratory and general medical physician at Wexford General Hospital (WGH).
A spokesperson for the Ireland East Hospital Group has confirmed to
Irish Medical Times that the death was not related to Covid-19.
“All the staff and management in Wexford General Hospital were profoundly sad to learn of the sudden passing of Dr Keshav Sharma this week,” the spokesperson added.
Digital healthcare training is key to successful EPR go-live In a recent webinar, NHS chief information officers outlined the challenges they encountered with training staff for big system go-lives and learned how uPerform by ANCILE Solutions could help to address them.
By:
10:14 AM
Research suggests that 70% of the success of an electronic patient record (EPR) project can rest on effective user adoption.
In a recent webinar hosted by ANCILE Solutions, healthcare experts discussed the challenges faced in running traditional training programmes and Bobby Zarr, senior director of healthcare strategy at ANCILE Solutions, described how uPerform helped him prepare for an Epic go-live at Infirmary Health in the US.
Yaqrit Discovery Ltd: Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure
Orally-administered,
non-absorbable engineered carbon, Carbalive
, was safe, tolerable and showed trends in improvements in a range of biomarkers of systemic inflammation associated with decompensated cirrhosis
Safety of novel dual filtration system, Dialive
, confirmed with liver failure patients more likely to see organ failure resolved and more quickly than control group
London, UK, 7 January 2021 - Yaqrit, a clinical stage life sciences company focused on developing potentially innovative treatments for patients with advanced liver disease in areas of high unmet medical need, today announces preliminary results from its randomised controlled clinical trials for two potential therapies from its pipeline of product candidates designed to address each stage of liver disease, from diagnosis of decompensated c
Yaqrit Discovery Ltd
Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure
Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure
Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure
Orally-administered,
non-absorbable engineered carbon, Carbalive
™, was safe, tolerable and showed trends in improvements in a range of biomarkers of systemic inflammation associated with decompensated cirrhosis
Safety of novel dual filtration system, Dialive
™, confirmed with liver failure patients more likely to see organ failure resolved and more quickly than control group
Científicos prueban un fármaco para inmunidad instantánea ante covid-19 invdes.com.mx - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invdes.com.mx Daily Mail and Mail on Sunday newspapers.